Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series

被引：18

作者：

Hoellinger, Baptiste ^{[1
,9
]}

Simand, Celestine ^{[2
]}

Jeannot, Katy ^{[3
]}

Garijo, Carlos ^{[4
]}

Cristinar, Mircea ^{[5
]}

Reisz, Fanny ^{[6
]}

Danion, Francois ^{[1
]}

Ursenbach, Axel ^{[1
]}

Lefebvre, Nicolas ^{[1
]}

Boyer, Pierre ^{[7
]}

Hansmann, Yves ^{[1
]}

Studer, Antoine ^{[8
]}

Schramm, Frederic

Ruch, Yvon ^{[1
]}

机构：

[1] Hop Univ Strasbourg, Dept Infect & Trop Dis, Strasbourg, France

[2] Strasbourg Univ, Inst Canc Strasbourg Europe, Dept Hematol, Strasbourg, France

[3] Ctr Hosp Univ Besancon, Ctr Natl Reference Resistance Antibiot, Lab Associe, Besancon, France

[4] Hop Univ Strasbourg, Serv Reanimat Med Hautepierre, Strasbourg, France

[5] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Chirurgicale, Strasbourg, France

[6] Hop Univ Strasbourg, Dept Pharm, Strasbourg, France

[7] Hop Univ Strasbourg, Dept Bacteriol, Strasbourg, France

[8] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Med Intens Reanimat, Strasbourg, France

[9] Hop Univ Strasbourg, Dept Infect Dis, F-67000 Strasbourg, France

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 03期

关键词：

D O I：

10.1016/j.cmi.2022.11.005

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：393 / 395

页数：3

共 6 条

[1] Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales [J].

Bonnin, Remy A. ;

Emeraud, Cecile ;

Jousset, Agnes B. ;

Naas, Thierry ;

Dortet, Laurent .

CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (08) :1156.e1-1156.e5

[2]

European Committee on Antimicrobial Susceptibility Testing, 2022, EUCAST BREAKP TABL I

[3]

European Committee on Antimicrobial Susceptibility Testing, GUID DOC BROTH MICR

[4] A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol [J].

Gatti, Milo ;

Bartoletti, Michele ;

Cojutti, Pier Giorgio ;

Gaibani, Paolo ;

Conti, Matteo ;

Giannella, Maddalena ;

Viale, Pierluigi ;

Pea, Federico .

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 :294-298

[5] Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance [J].

Karakonstantis, Stamatis ;

Rousaki, Maria ;

Kritsotakis, Evangelos, I .

ANTIBIOTICS-BASEL, 2022, 11 (06)

[6] Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections [J].

Meschiari, Marianna ;

Volpi, Sara ;

Faltoni, Matteo ;

Dolci, Giovanni ;

Orlando, Gabriella ;

Franceschini, Erica ;

Menozzi, Marianna ;

Sarti, Mario ;

Del Fabro, Giovanni ;

Fumarola, Benedetta ;

Guarneri, Francesco ;

Lanza, Paola ;

Lorenzotti, Silvia ;

Saccani, Barbara ;

Signorini, Liana ;

Van Hauwermeiren, Evelyn ;

Gatti, Milo ;

Pea, Federico ;

Castelli, Francesco ;

Mussini, Cristina .

JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (04)

← 1 →